Looking at retrospective data, researchers found immunodeficiency was much more frequent in C. diff patients than in the control group, at 46 percent and 6 percent, respectively. Additionally, 24 percent of C. diff patients had been recently hospitalized and exposed to antibiotics, compared to only three percent of the control group.
The data also show symptomatic abdominal pain reported at time of admission was more common in the control group, while more C. diff patients had a history of gastrointestinal disease, GI surgery or abdominal surgery.
The number of patients with diarrhea is comparable between the two groups, suggesting diarrhea itself is not necessarily an indicator of a C. diff infection.
The authors suggest a history of immunodeficiency and persistent GI factors could be strong indicators of C. diff, even when traditional risk factors like recent hospitalization are absent. They also suggest using these factors to create an assessment tool could aid physicians in C. diff diagnoses.
More Articles on C. diff:
Many Treated for C. diff Not Actually Infected
C. diff Data Biased, Study Shows
Hospital Compare Adds C. diff, MRSA Data
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
